Search

everythinglearnresearchcommunity

for

Search:↓

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The study concluded that hirsutism is most common in women aged 14 to 48, often caused by PCOS, and can be effectively treated with Nd YAG laser and IPL.

Hirsutism greatly impacts women's mental well-being and finances.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Spironolactone can reduce hair growth in women with hirsutism.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.